Form 4 for CRDF Cardiff Oncology, Inc.
Accepted 2022-09-19 00:00:00 ET · period of report 2022-09-15 · accession 0001628280-22-025100 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-19 | 2022-09-15 | CRDF | PACE GARY W | Dir | P - Purchase | $1.71 | +150.0K | 644.8K | +30% | +$256.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-15 | P | A | 150,000 | $1.71 | 644,811 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.65 to $1.78. Full information regarding the number of shares purcahsed at each separate price can be furnished to the SEC staff upon request. |